Abstract:This article reports a promising approach to enhance the oral delivery of nuciferine (NUC), improve its aqueous solubility and bioavailability, and allow its controlled release as well as inhibiting lipid accumulation. NUC-loaded poly lactic-co-glycolic acid nanoparticles (NUC-PLGA-NPs) were prepared according to a solid/oil/water (s/o/w) emulsion technique due to the water-insolubility of NUC. PLGA exhibited excellent loading capacity for NUC with adjustable dosing ratios. The drug loading and encapsulation efficiency of optimized formulation were 8.89 ± 0.71 and 88.54 ± 7.08%, respectively. NUC-PLGA-NPs exhibited a spherical morphology with average size of 150.83 ± 5.72 nm and negative charge of −22.73 ± 1.63 mV, which are suitable for oral administration. A sustained NUC released from NUC-PLGA-NPs with an initial exponential release owing to the surface associated drug followed by a slower release of NUC, which was entrapped in the core. In addition, ∼77 ± 6.67% was released in simulating intestinal juice, while only about 45.95 ± 5.2% in simulating gastric juice. NUC-PLGA-NPs are more efficient against oleic acid (OA)-induced hepatic steatosis in HepG2 cells when compared to naked NUC (n-NUC, *p < 0.05). The oral bioavailability of NUC-PLGA-NPs group was significantly higher (**p < 0.01) and a significantly decreased serum levels of total cholesterol (TC), triglycerides (TG) and low-density lipoprotein cholesterol (LDL-C), as well as a higher concentration of high-density lipoprotein cholesterol (HDL-C) was observed, compared with that of n-NUC treated group. These findings suggest that NUC-PLGA-NPs hold great promise for sustained and controlled drug delivery with improved bioavailability to alleviating lipogenesis.

Preparation of Neferine-Loaded PLGA Nanoparticles Using Precipitation Method

Preparation of PLGA Nanoparticles Loading Tetrandrine and Its Release in Vivo

HPLC-ELSD Method to Determine Encapsulating Efficiency and Loading Capacity of Ginkgolide B in PEG-PLGA Nanoparticles

Caffeic Acid Phenethyl Ester Loaded PLGA Nanoparticles: Effect of Various Process Parameters on Reaction Yield, Encapsulation Efficiency, and Particle Size

Lipid-Polymer Hybrid Nanoparticles Synthesized via Lipid-Based Surface Engineering for a robust drug delivery platform

The Effect of Different Factors on Poly(lactic-co-glycolic acid) Nanoparticle Properties and Drug Release Behaviors When Co-Loaded with Hydrophilic and Hydrophobic Drugs

Optimized Preparation of Levofloxacin Loaded Polymeric Nanoparticles

PLGA Nanoparticles for the Oral Delivery of Nuciferine: Preparation, Physicochemical Characterization and in Vitro/in Vivo Studies

[Study on Preparation and Oral Efficacy of Insulin-Loaded Poly(lactic-Co-glycolic Acid) Nanoparticles].

High Yield and High Loading Preparation of Curcumin-Plga Nanoparticles Using A Modified Supercritical Antisolvent Technique

Preparation,optimization and Characterization of NC-1900 Loaded MePEG-PLA Nanoparticles

Preparation and quality evaluation of vincristine sulfate-loaded PEG-PLGA nanoparticles

Preparation and Physicochemical Properties of Ginkgolide PELGE Nanoparticles

Optimizing Preparation of Arsenic Trioxide-Loaded Polylacticco-Glycolic Nanoparticles

Preparation of erythrocyte membrane-camouflaged PLGA nanoparticles and preliminary investigation on their cytotoxicity and drug release in vitro

Preparation and Physical Characterization of Poly-Lactic-co-glycolic Acid Nanoparticles Loaded with Thymopentin for Oral Administration

Preparation and Characterization of Oridonin-loaded Poly (caprolactone)-Poly (ethylene oxide)-Poly (caprolactone) Copolymer Nanoparticles

Drug-nanoencapsulated PLGA Microspheres Prepared by Emulsion Electrospray with Controlled Release Behavior

Preparation and Characterization of Shell Cross-linked PLGA Nanoparticles with pH-responsiveness for Drug Delivery

Controllable Microfluidic Production of Drug-Loaded PLGA Nanoparticles Using Partially Water-Miscible Mixed Solvent Microdroplets as a Precursor

Preparation and Characterization of Biodegradable Nanoparticles from Methoxy Poly(ethylene Glycol)-Poly(d,l-lactide)block Copolymers As Novel Drug Carriers